|
1
|
Goetze JP, Bruneau BG, Ramos HR, Ogawa T,
de Bold MK and de Bold AJ: Cardiac natriuretic peptides. Nat Rev
Cardiol. 17:698–717. 2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Hedner T, Hedner J, Andersson O, Persson B
and Pettersson A: ANP-a cardiac hormone and a putative central
neurotransmitter. Eur Heart J. 8 (Suppl 2):S87–S98. 1987.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Rubattu S, Sciarretta S, Marchitti S,
Bianchi F, Forte M and Volpe M: The T2238C human atrial natriuretic
peptide molecular variant and the risk of cardiovascular diseases.
Int J Mol Sci. 19(540)2018.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Kuwahara K: The natriuretic peptide system
in heart failure: Diagnostic and therapeutic implications.
Pharmacol Ther. 227(107863)2021.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Rahmutula D, Nakayama T, Soma M, Takahashi
Y, Kunimoto M, Uwabo J, Sato M, Izumi Y, Kanmatsuse K and Ozawa Y:
Association study between the variants of the human ANP gene and
essential hypertension. Hypertens Res. 24:291–294. 2001.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Rubattu S, Sciarretta S and Volpe M:
Atrial natriuretic peptide gene variants and circulating levels:
Implications in cardiovascular diseases. Clin Sci (Lond). 127:1–13.
2014.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Cannone V, Cabassi A, Volpi R and Burnett
JC Jr: Atrial natriuretic peptide: A molecular target of novel
therapeutic approaches to cardio-metabolic disease. Int J Mol Sci.
20(3265)2019.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Larifla L, Maimaitiming S,
Velayoudom-Cephise FL, Ferdinand S, Blanchet-Deverly A, Benabdallah
S, Donnet JP, Atallah A, Roussel R and Foucan L: Association of
2238T>C polymorphism of the atrial natriuretic peptide gene with
coronary artery disease in Afro-Caribbeans with type 2 diabetes. Am
J Hypertens. 25:524–527. 2012.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Wu Z, Xu M, Sheng H, Lou Y, Su X, Chen Y,
Lu L, Liu Y and Jin W: Association of natriuretic peptide
polymorphisms with left ventricular dysfunction in southern Han
Chinese coronary artery disease patients. Int J Clin Exp Pathol.
7:7148–7157. 2014.PubMed/NCBI
|
|
10
|
Takagi G, Kiuchi K, Endo T, Yamamoto T,
Sato N, Nejima J and Takano T: Alpha-human atrial natriuretic
peptide, carperitide, reduces infarct size but not arrhythmias
after coronary occlusion/reperfusion in dogs. J Cardiovasc
Pharmacol. 36:22–30. 2000.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Lynch AI, Boerwinkle E, Davis BR, Ford CE,
Eckfeldt JH, Leiendecker-Foster C and Arnett DK: Pharmacogenetic
association of the NPPA T2238C genetic variant with cardiovascular
disease outcomes in patients with hypertension. JAMA. 299:296–307.
2008.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Stanzione R, Sciarretta S, Marchitti S,
Bianchi F, Di Castro S, Scarpino S, Cotugno M, Frati G, Volpe M and
Rubattu S: C2238/αANP modulates apolipoprotein E through
Egr-1/miR199a in vascular smooth muscle cells in vitro. Cell Death
Dis. 6(e2033)2015.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Pastori D, Carnevale R, Stanzione R,
Nocella C, Cotugno M, Marchitti S, Bianchi F, Forte M, Valenti V,
Biondi-Zoccai G, et al: T2238C atrial natriuretic peptide gene
variant and cardiovascular events in patients with atrial
fibrillation: A substudy from the ATHERO-AF cohort. Int J Cardiol.
322:245–249. 2021.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Page MJ, McKenzie JE, Bossuyt PM, Boutron
I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan
SE, et al: The PRISMA 2020 statement: An updated guideline for
reporting systematic reviews. BMJ. 372(n71)2021.PubMed/NCBI View
Article : Google Scholar
|
|
15
|
Stang A: Critical evaluation of the
Newcastle-Ottawa scale for the assessment of the quality of
nonrandomized studies in meta-analyses. Eur J Epidemiol.
25:603–605. 2010.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Gruchala M, Ciećwierz D, Wasag B,
Targoński R, Dubaniewicz W, Nowak A, Sobiczewski W, Ochman K,
Romanowski P, Limon J and Rynkiewicz A: Association of the ScaI
atrial natriuretic peptide gene polymorphism with nonfatal
myocardial infarction and extent of coronary artery disease. Am
Heart J. 145:125–131. 2003.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Rubattu S, Stanzione R, Di Angelantonio E,
Zanda B, Evangelista A, Tarasi D, Gigante B, Pirisi A, Brunetti E
and Volpe M: Atrial natriuretic peptide gene polymorphisms and risk
of ischemic stroke in humans. Stroke. 35:814–818. 2004.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Zhang L, Cheng L, He M, Hu B and Wu T: ANP
T2238C, C-664G gene polymorphism and coronary heart disease in
Chinese population. J Huazhong Univ Sci Technolog Med Sci.
26:528–530. 2006.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Barbato E, Bartunek J, Mangiacapra F,
Sciarretta S, Stanzione R, Delrue L, Cotugno M, Marchitti S,
Iaccarino G, Sirico G, et al: Influence of rs5065 atrial
natriuretic peptide gene variant on coronary artery disease. J Am
Coll Cardiol. 59:1763–1770. 2012.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Cannone V, Huntley BK, Olson TM, Heublein
DM, Scott CG, Bailey KR, Redfield MM, Rodeheffer RJ and Burnett JC
Jr: Atrial natriuretic peptide genetic variant rs5065 and risk for
cardiovascular disease in the general community: A 9-year follow-up
study. Hypertension. 62:860–865. 2013.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Francia P, Ricotta A, Frattari A,
Stanzione R, Modestino A, Mercanti F, Adduci C, Sensini I, Cotugno
M, Balla C, et al: Atrial natriuretic peptide single nucleotide
polymorphisms in patients with nonfamilial structural atrial
fibrillation. Clin Med Insights Cardiol. 7:153–159. 2013.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Ziaee S, Kalayinia S, Boroumand MA,
Pourgholi L, Cheraghi S, Anvari MS and Sheikhvatan M: Association
between the atrial natriuretic peptide rs5065 gene polymorphism and
the presence and severity of coronary artery disease in an Iranian
population. Coron Artery Dis. 25:242–246. 2014.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Rubattu S, De Giusti M, Farcomeni A,
Abbolito S, Comito F, Cangianiello S, Greco ES, Dito E, Pagliaro B,
Cotugno M, et al: T2238C ANP gene variant and risk of recurrent
acute coronary syndromes in an Italian cohort of ischemic heart
disease patients. J Cardiovasc Med (Hagerstown). 17:601–607.
2016.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Siebert J, Lewicki Ł, Myśliwska J,
Młotkowska M and Rogowski J: ScaI atrial natriuretic peptide gene
polymorphisms and their possible association with postoperative
atrial fibrillation-a preliminary report. Arch Med Sci. 13:568–574.
2017.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Oikonomou E, Zografos T, Papamikroulis GA,
Siasos G, Vogiatzi G, Theofilis P, Briasoulis A, Papaioannou S,
Vavuranakis M, Gennimata V and Tousoulis D: Biomarkers in atrial
fibrillation and heart failure. Curr Med Chem. 26:873–887.
2019.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Ilatovskaya DV, Levchenko V, Winsor K,
Blass GR, Spires DR, Sarsenova E, Polina I, Zietara A, Paterson M,
Kriegel AJ and Staruschenko A: Effects of elevation of ANP and its
deficiency on cardiorenal function. JCI Insight.
7(e148682)2022.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Gerbes AL: The role of atrial natriuretic
peptide (ANP) in chronic liver disease. Pharmacol Ther. 58:381–390.
1993.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Nakagawa Y, Nishikimi T and Kuwahara K:
Atrial and brain natriuretic peptides: Hormones secreted from the
heart. Peptides. 111:18–25. 2019.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Melo LG, Steinhelper ME, Pang SC, Tse Y
and Ackermann U: ANP in regulation of arterial pressure and
fluid-electrolyte balance: Lessons from genetic mouse models.
Physiol Genomics. 3:45–58. 2000.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Cannone V, Boerrigter G, Cataliotti A,
Costello-Boerrigter LC, Olson TM, McKie PM, Heublein DM, Lahr BD,
Bailey KR, Averna M, et al: A genetic variant of the atrial
natriuretic peptide gene is associated with cardiometabolic
protection in the general community. J Am Coll Cardiol. 58:629–636.
2011.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Sarnowski C, Satizabal CL, DeCarli C,
Pitsillides AN, Cupples LA, Vasan RS, Wilson JG, Bis JC, Fornage M,
Beiser AS, et al: Whole genome sequence analyses of brain imaging
measures in the Framingham study. Neurology. 90:e188–e196.
2018.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Tunny TJ, Jonsson JR, Klemm SA, Ballantine
DM, Stowasser M and Gordon RD: Association of restriction fragment
length polymorphism at the atrial natriuretic peptide gene locus
with aldosterone responsiveness to angiotensin in
aldosterone-producing adenoma. Biochem Biophys Res Commun.
204:1312–1317. 1994.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Melo LG, Veress AT, Ackermann U and
Sonnenberg H: Chronic regulation of arterial blood pressure by ANP:
Role of endogenous vasoactive endothelial factors. Am J Physiol.
275:H1826–H1833. 1998.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Cabiati M, Raucci S, Liistro T, Belcastro
E, Prescimone T, Caselli C, Matteucci M, Iozzo P, Mattii L,
Giannessi D and Del Ry S: Impact of obesity on the expression
profile of natriuretic peptide system in a rat experimental model.
PLoS One. 8(e72959)2013.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Gaudino M, Andreotti F, Zamparelli R, Di
Castelnuovo A, Nasso G, Burzotta F, Iacoviello L, Donati MB,
Schiavello R, Maseri A and Possati G: The-174G/C interleukin-6
polymorphism influences postoperative interleukin-6 levels and
postoperative atrial fibrillation. Is atrial fibrillation an
inflammatory complication? Circulation. 108 (Suppl 1):II195–II199.
2003.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Sezai A, Shiono M, Orime Y, Hata H, Hata
M, Negishi N and Sezai Y: Low-dose continuous infusion of human
atrial natriuretic peptide during and after cardiac surgery. Ann
Thorac Surg. 69:732–738. 2000.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Ardizzone N, Cappello F, Di Felice V,
Rappa F, Minervini F, Marasà S, Marasà L, Rabl W, Zummo G and Sergi
C: Atrial natriuretic peptide and CD34 overexpression in human
idiopathic dilated cardiomyopathies. APMIS. 115:1227–1233.
2007.PubMed/NCBI View Article : Google Scholar
|
